No confirmed Trump executive order or enacted federal law has created a new nationwide abortion-surveillance program. The documented federal proposal is S.178, a Senate bill introduced on January 22, 2025, that would mandate aggregate abortion reporting and use Medicaid funding to enforce state participation. Here, "surveillance" means collecting population-level abortion statistics, not a stated federal registry of named patients. Still, the proposed data fields, funding penalties, reporting delays, and possible future uses raise serious ethics and accountability questions.
Table of Contents
- What would S.178 require?
- How would federal spending enforce compliance?
- What are the central privacy and ethics questions?
- Would the public receive timely information?
- How should readers evaluate new claims?
What would S.178 require?
S.178 would direct the Centers for Disease Control and Prevention to maintain a standardized national abortion-data system. States would submit aggregate information rather than patient-level records. Required categories would include age, gestational age, race or ethnicity, abortion method, marital status, previous pregnancies, and county and state of residence.
The text of S.178 on Congress.gov does not establish an individual financial penalty for obtaining an abortion. The CDC already operates an abortion surveillance system using voluntarily submitted state data. According to the CDC's description of that system, there is no national reporting requirement. S.178 would primarily change participation, consistency, and enforcement—not create federal abortion-data collection from nothing.
How would federal spending enforce compliance?
S.178 would tie specified federal Medicaid payments for family-planning services to timely state reporting. The financial pressure would fall directly on noncompliant states, not individual patients. The CDC could withhold those payments for an entire fiscal year after determining that a state knowingly submitted false abortion data.
That creates a significant spending lever even though the bill does not describe the withholding as a patient penalty. The practical risk extends beyond state budgets. People who rely on affected family-planning services could feel downstream effects if a state lost funding. The bill's text alone does not establish whether a funding loss would reduce services, force states to replace federal money, or produce another response.
What are the central privacy and ethics questions?
Aggregate reporting offers more privacy than a database containing names or complete medical records. But detailed combinations—such as county, age, race, method, and gestational age—can still create confidentiality concerns, especially where few cases appear in a category. The key safeguards are therefore not limited to removing names.
Policymakers should explain how small groups would be suppressed, who could access underlying submissions, how long records would remain available, and whether agencies could repurpose the data. Project 2025 is separate from S.178 and is not itself federal law. Its Department of Health and human Services blueprint recommends using federal funding pressure to obtain broader state reporting, including reasons, complications, residence, methods, and certain pregnancy outcomes. Readers should not merge the two proposals, but the blueprint shows why limits on future collection and use matter.
Would the public receive timely information?
S.178 would require an annual public report, but it could appear as late as December 30 of the third calendar year after the year covered. Under that timetable, a report covering 2025 could arrive on December 30, 2028.
That delay weakens the report's value for tracking current policy effects, spending decisions, or sudden changes in access. Standardized national data may improve long-term comparisons while remaining too old for real-time oversight. Meaningful transparency would also require information the published statistics may not reveal: which states submitted late, when the CDC found data unreliable, whether funding was withheld, and how privacy rules shaped public tables.
How should readers evaluate new claims?
Trump administration interest does not establish that a nationwide mandate exists. At a July 15, 2026 Senate nomination hearing, Trump CDC nominee Erica Schwartz called abortion surveillance "a critical component" of the agency's work. That statement signals interest, but it does not enact S.178 or create a program by itself.
The Government Accountability Office reported in May 2025 that the future of the CDC's voluntary collection was uncertain amid agency realignment. GAO also found that abortion restrictions can cause negative economic effects for affected women and families, making both data quality and collection costs consequential. Before treating a headline as settled policy, readers should:.
- Check Congress.gov for S.178's current legislative status.
- Separate bill requirements from Project 2025 recommendations and nominee statements.
- Look for explicit privacy rules covering small groups, access, retention, and secondary use.
- Identify which Medicaid payments could be withheld and whether a state has replacement funding.
- Compare the data year with the publication date before using a report to describe current conditions.